A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
Top Cited Papers
- 14 December 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 66 (11), 1698-1704
- https://doi.org/10.1093/cid/cix1082
Abstract
BackgroundThe annual standard dose influenza vaccine has suboptimal immunogenicity in solid organ transplant recipients (SOTR). Influenza vaccine containing higher doses of antigens may lead to greater immunogenicity in this population.MethodsWe conducted a randomized, double blind trial comparing the safety and immunogenicity of the 2016-17 high dose (HD; FluzoneHD,Sanofi) versus standard dose (SD; Fluviral,GSK) influenza vaccine in adult SOTR. Preimmunization and 4-week postimmunization sera underwent strain-specific hemagglutination inhibition assay.ResultsWe enrolled 172 patients who received study vaccine and 161 (84 HD; 77 SD) were eligible for analysis. Seroconversion to at least 1 of 3 vaccine antigens was present in 78.6% vs. 55.8% in HD vs. SD vaccine respectively (p<0.001). Seroconversion to A/ H1N1, A/H3N2 and B strains were 40.5% vs. 20.5%, 57.1% vs. 32.5%, and 58.3% vs. 41.6% in HD vs. SD vaccine (p=0.006, 0.002, 0.028 respectively). Post-immunization geometric mean titers of A/H1N1, A/H3N2, and B strains were significantly higher in HD group (p=0.007, 0.002, 0.033). Independent factors associated with seroconversion to at least one vaccine strain were the use of HD vaccine (OR 3.23, 95% CI 1.56-6.67) and use of mycophenolate doses less than 2g daily (OR 2.76, 95% CI 1.12-6.76).ConclusionsHigh-dose vaccine demonstrated significantly better immunogenicity than SD vaccine in adult transplant recipients and may be the preferred influenza vaccine for this population.Keywords
This publication has 27 references indexed in Scilit:
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in ChildrenThe Pediatric Infectious Disease Journal, 2011
- Influenza vaccine responses in older adultsAgeing Research Reviews, 2011
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort studyThe Lancet Infectious Diseases, 2010
- Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Influenza Vaccination Is Efficacious and Safe in Renal Transplant RecipientsAmerican Journal of Transplantation, 2008
- Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsVaccine, 2007
- Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant RecipientsAmerican Journal of Transplantation, 2007
- Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant PatientsAmerican Journal of Transplantation, 2004
- Comparison of Complement Fixation and Hemagglutination Inhibition Assays for Detecting Antibody Responses following Influenza Virus VaccinationClinical and Vaccine Immunology, 2003